Enabling Technologies for Precision Drug Delivery in the GI Tract


Soteria® is a revolutionary new technology that allows patients to take biopharmaceutical drugs, including monoclonal antibodies, as a simple and safe tablet or capsule.


Phloral® is a cutting-edge technology for precise and consistent delivery to the colon. It exploits changes in gastrointestinal pH in combination with the enzymatic activity of the microbiota as independent but complementary release mechanisms to guarantee site-specific release.

Pipeline of Oral Antibodies

Featured News

Intract Pharma to Present at the 22nd BIO CEO & Investor Conference

Intract’s Soteria® and Phloral® Technologies Highlighted Among Revolutionary Approaches to Crack Oral Biologics Delivery Challenge

Carus Animal Health and Intract Pharma Enter Agreement to Develop Novel Drug Delivery Technology